Chlorosulfaquinoxaline
Alternative Names: Chloroquinoxaline sulfonamide; Chloroquinoxalone; CQS; NSC 339004Latest Information Update: 06 Nov 2002
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Non-small cell lung cancer